The Therapeutic Goods Administration (TGA) has issued 3 infringement notices totalling $11,880 to a nurse for the alleged unlawful importation of unapproved cosmetic injectables, which is illegal under the Therapeutic Goods Act 1989 (the Act).
The New South Wales nurse, who is registered with the Australian Health Practitioner Regulation Agency, allegedly imported unapproved vials of botulinum toxin and pre-filled syringes containing lidocaine.
The infringement notices were issued to the nurse in May 2026.
Therapeutic goods that are not listed in the Australian Register of Therapeutic Goods, also known as unapproved therapeutic goods, have not been assessed by the TGA for quality, safety and efficacy and therefore may pose a health risk.
Individuals, health practitioners and businesses must understand their legal obligations under the Act before importing therapeutic goods. Consequences for non-compliance may include infringement notices, direction or prevention notices, or civil or criminal proceedings.
The TGA works in partnership with law enforcement agencies, other health regulators, and state and territory authorities to address unlawful activity in the wellness and beauty industries.
In recognition of their potential harm and increased use, the TGA is targeting unapproved therapeutic goods used in cosmetic procedures as part of its Compliance Principles 2026 and 2027.
If you suspect non-compliance in relation to therapeutic goods, or their advertising, you can report it to the TGA at any time.
